GC Biopharma Corp. (KRX:006280)
South Korea · Delayed Price · Currency is KRW 140,100
-1,500 (-1.06%)
Apr 28, 2026, 3:30 PM KST
GC Biopharma Market Cap
GC Biopharma has a market cap or net worth of 1.6 trillion as of April 28, 2026. Its market cap has increased by 11.10% in one year.
Market Cap
1.60T
Enterprise Value
2.71T
Revenue
1.99T
Ranking
n/a
PE Ratio
n/a
Stock Price
140,100.00
Market Cap Chart
Since August 29, 1995, GC Biopharma's market cap has increased from 29.09B to 1.60T, an increase of 5,397.46%. That is a compound annual growth rate of 13.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 1.60T | -11.89% |
| Dec 30, 2025 | 1.81T | -11.42% |
| Dec 30, 2024 | 2.05T | 43.03% |
| Dec 28, 2023 | 1.43T | -3.09% |
| Dec 29, 2022 | 1.48T | -40.60% |
| Dec 30, 2021 | 2.49T | -46.31% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hanall Biopharma | 2.63T |
| Celltrion Pharm | 2.56T |
| Daewoong Pharmaceutical | 1.72T |
| Chong Kun Dang Pharmaceutical | 1.16T |
| DongKook Pharmaceutical | 1.14T |
| Daewoong | 942.53B |
| Ildong Pharmaceutical | 885.38B |
| Boryung | 843.12B |